Federated Hermes
IRWD icon

Federated Hermes’s Ironwood Pharmaceuticals IRWD Stock Holding History

Federated Hermes’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6M Sell
3,231,238
-117,568
-4% -$453K 0.02% 592
2026
Q1 		$11.8M Buy
3,348,806
+30,669
+0.9% +$126K 0.02% 590
2025
Q4 		$11.2M Buy
3,318,137
+1,161,033
+54% +$3.02M 0.02% 584
2025
Q3 		$2.83M Sell
2,157,104
-19,934
-0.9% -$20.6K 0.01% 859
2025
Q2 		$1.56M Buy
2,177,038
+871,676
+67% +$684K ﹤0.01% 1000
2025
Q1 		$1.92M Buy
1,305,362
+934,886
+252% +$2.23M ﹤0.01% 941
2024
Q4 		$1.64M Buy
+370,476
New +$1.5M ﹤0.01% 980
2023
Q3 		– Sell
-1,064
Closed -$11.3K – 2147
2023
Q2 		$11.3K Buy
1,064
+359
+51% +$3.86K ﹤0.01% 1836
2023
Q1 		$7.42K Buy
705
+12
+2% +$134 ﹤0.01% 1899
2022
Q4 		$8.59K Sell
693
-1,274
-65% -$14.5K ﹤0.01% 1883
2022
Q3 		$20K Sell
1,967
-1,199
-38% -$13.6K ﹤0.01% 1769
2022
Q2 		$37K Sell
3,166
-127,084
-98% -$1.5M ﹤0.01% 1700
2022
Q1 		$1.64M Sell
130,250
-370,569
-74% -$4.25M ﹤0.01% 1094
2021
Q4 		$5.84M Buy
500,819
+619
+0.1% +$7.59K 0.01% 777
2021
Q3 		$6.53M Buy
500,200
+19,425
+4% +$251K 0.01% 761
2021
Q2 		$6.19M Sell
480,775
-6,613
-1% -$75.7K 0.01% 785
2021
Q1 		$5.45M Sell
487,388
-15,359
-3% -$162K 0.01% 830
2020
Q4 		$5.73M Buy
502,747
+1,406
+0.3% +$15.4K 0.01% 776
2020
Q3 		$4.51M Sell
501,341
-87,376
-15% -$868K 0.01% 755
2020
Q2 		$6.08M Buy
588,717
+6,547
+1% +$67K 0.02% 663
2020
Q1 		$5.87M Buy
582,170
+76,485
+15% +$899K 0.02% 591
2019
Q4 		$6.73M Buy
+505,685
New +$5.58M 0.02% 693
2018
Q4 		– Sell
-132,904
Closed -$2.06M – 2250
2018
Q3 		$2.06M Buy
+132,904
New +$2.1M ﹤0.01% 1082
2017
Q2 		– Sell
-41,731
Closed -$596K – 2154
2017
Q1 		$596K Buy
+41,731
New +$571K ﹤0.01% 1295

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Federated Hermes's IRWD Position: Q2 2026 in Review

Federated Hermes reduced its Ironwood Pharmaceuticals (IRWD) stake by 3.5% in Q2 2026, selling an estimated $453K and leaving 3,231,238 shares worth $13.6M. The position accounts for 0.02% of the portfolio, ranked #592.

Federated Hermes first reported a position in IRWD in Q1 2017 and has held it in 24 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Federated Hermes held 3,231,238 shares of Ironwood Pharmaceuticals worth $13.6M as of Q2 2026.
  • Federated Hermes sold 117,568 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $453K.
  • Ironwood Pharmaceuticals made up 0.02% of Federated Hermes's portfolio in Q2 2026, its #592 holding.
  • Federated Hermes first reported a position in Ironwood Pharmaceuticals in Q1 2017 and has held it in 24 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.